SLC3A2 and Miyoshi myopathy: KRASG12D+T148D demonstrated significantly higher expression and had increased association with known RAS signaling effectors in MM, including RAF1, RALA, and SLC3A2, relative to KRASG12D+T148A (Fig. 2G, Table S3)14.